BAKER BROS. ADVISORS LP – Krystal Biotech, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$29.42M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+6.15%
quarter
Krystal Biotech, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -47.73% | -385.55K shares | -23.61M | $69.7 | 422.18K |
| Q2 2022 | share | 0.00% | 0 shares | -711K | $65.66 | 807.73K | |
| Q1 2022 | share | 0.00% | 0 shares | -2.75M | $66.54 | 807.73K | |
| Q4 2021 | share | Increase | +32.91% | 200K shares | 24.77M | $70.5 | 807.73K |
| Q3 2021 | share | 0.00% | 0 shares | -9.59M | $52.21 | 607.73K | |
| Q2 2021 | share | Decrease | -20.08% | -152.67K shares | -17.25M | $68 | 607.73K |
| Q1 2021 | share | Increase | +8.81% | 61.53K shares | 16.65M | $77.04 | 760.41K |
| Q4 2020 | share | Decrease | -9.85% | -76.31K shares | 8.56M | $60 | 698.87K |
| Q3 2020 | share | Decrease | -5.19% | -42.43K shares | -494K | $43.05 | 775.19K |
| Q2 2020 | share | Decrease | -13.61% | -128.84K shares | -7.05M | $41.42 | 817.63K |
| Q1 2020 | share | Decrease | -8.52% | -88.20K shares | -16.37M | $43.24 | 946.47K |
| Q4 2019 | share | 0.00% | 0 shares | 21.37M | $55.38 | 1.03M | |
| Q3 2019 | share | 0.00% | 0 shares | -5.73M | $34.73 | 1.03M | |
| Q2 2019 | share | Increase | +31.86% | 250K shares | 15.85M | $40.27 | 1.03M |
| Q1 2019 | share | 0.00% | 0 shares | 9.51M | $32.9 | 784.67K | |
| Q4 2018 | share | Increase | +584.26% | 670K shares | 14.29M | $20.78 | 784.67K |
| Q3 2018 | share | Decrease | -42.66% | -85.32K shares | -958K | $17.58 | 114.67K |
| Q2 2018 | share | 0.00% | 0 shares | 956K | $14.87 | 200K | |
| Q1 2018 | share | 0.00% | 0 shares | -86K | $10.09 | 200K | |
| Q4 2017 | share | 0.00% | 0 shares | 110K | $10.52 | 200K | |
| Q3 2017 | share | Increase | 0.00% | 200K shares | 1.99M | $9.97 | 200K |